209 related articles for article (PubMed ID: 11191055)
21. Structural basis for the functions of endogenous angiogenesis inhibitors.
Grant MA; Kalluri R
Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
[TBL] [Abstract][Full Text] [Related]
22. Making the cut: protease-mediated regulation of angiogenesis.
Roy R; Zhang B; Moses MA
Exp Cell Res; 2006 Mar; 312(5):608-22. PubMed ID: 16442099
[TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay.
Guedez L; Rivera AM; Salloum R; Miller ML; Diegmueller JJ; Bungay PM; Stetler-Stevenson WG
Am J Pathol; 2003 May; 162(5):1431-9. PubMed ID: 12707026
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis: a dynamic balance of stimulators and inhibitors.
Iruela-Arispe ML; Dvorak HF
Thromb Haemost; 1997 Jul; 78(1):672-7. PubMed ID: 9198237
[TBL] [Abstract][Full Text] [Related]
25. [Angiogenesis, lymphangiogenesis, and tumor progression].
Hawighorst T
Zentralbl Gynakol; 2002 Nov; 124(11):497-505. PubMed ID: 12796842
[TBL] [Abstract][Full Text] [Related]
26. The ubiquitin-proteasome system meets angiogenesis.
Rahimi N
Mol Cancer Ther; 2012 Mar; 11(3):538-48. PubMed ID: 22357635
[TBL] [Abstract][Full Text] [Related]
27. Tumor angiogenesis in gastric cancer.
Lazăr D; Raica M; Sporea I; Tăban S; Goldiş A; Cornianu M
Rom J Morphol Embryol; 2006; 47(1):5-13. PubMed ID: 16838051
[TBL] [Abstract][Full Text] [Related]
28. Role of the tumor microenvironment in mediating response to anti-angiogenic therapy.
Jung YD; Ahmad SA; Akagi Y; Takahashi Y; Liu W; Reinmuth N; Shaheen RM; Fan F; Ellis LM
Cancer Metastasis Rev; 2000; 19(1-2):147-57. PubMed ID: 11191054
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis.
Sargiannidou I; Qiu C; Tuszynski GP
Semin Thromb Hemost; 2004 Feb; 30(1):127-36. PubMed ID: 15034804
[TBL] [Abstract][Full Text] [Related]
30. Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases.
Grimm D; Bauer J; Schoenberger J
Curr Vasc Pharmacol; 2009 Jul; 7(3):347-57. PubMed ID: 19601859
[TBL] [Abstract][Full Text] [Related]
31. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
32. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
33. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
34. The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential.
Kuno K; Bannai K; Hakozaki M; Matsushima K; Hirose K
Biochem Biophys Res Commun; 2004 Jul; 319(4):1327-33. PubMed ID: 15194513
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
Oklu R; Walker TG; Wicky S; Hesketh R
J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
[TBL] [Abstract][Full Text] [Related]
36. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
37. Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.
Daugimont L; Vandermeulen G; Defresne F; Bouzin C; Mir LM; Bouquet C; Feron O; Préat V
Eur J Pharm Biopharm; 2011 Aug; 78(3):314-9. PubMed ID: 21316447
[TBL] [Abstract][Full Text] [Related]
38. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.
Volpert OV; Lawler J; Bouck NP
Proc Natl Acad Sci U S A; 1998 May; 95(11):6343-8. PubMed ID: 9600967
[TBL] [Abstract][Full Text] [Related]
39. Tumor microenvironment and angiogenesis.
Nyberg P; Salo T; Kalluri R
Front Biosci; 2008 May; 13():6537-53. PubMed ID: 18508679
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis: new insights and therapeutic potential.
Tomanek RJ; Schatteman GC
Anat Rec; 2000 Jun; 261(3):126-35. PubMed ID: 10867630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
